SCHEMBL23726231

SCHEMBL23726231

[CH2]c1nc2cc(Br)ccn2c(=O)c1C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 3/20 0.38
CASP3 P42574 4/20 0.36
AHR P35869 2/20 0.33
GAA P10253 2/20 0.33
PKM P14618 1/20 0.33
POLB P06746 2/20 0.33
MAPT P10636 1/20 0.33
RECQL P46063 1/20 0.33
AKT2 P31751 1/20 0.31
PARP1 P09874 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
GLA P06280 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28903524 0.86 KDM4E (0.41) KDM4EALDH1A1CASP3AHRGAA
SCHEMBL23725667 0.80 KDM4E (0.36) KDM4EALDH1A1CASP3AHRGAA
SCHEMBL23473930 0.79 KDM5B (0.40) KDM4EALDH1A1AKT2MEN1KMT2A
SCHEMBL23726594 0.74 MAPT (0.41) KDM4EALDH1A1GAAPOLBMAPT
SCHEMBL28903307 0.73 KDM4E (0.44) KDM4EALDH1A1CASP3AHRPKM
SCHEMBL18015431 0.73 KDM4E (0.70) KDM4EALDH1A1CASP3AHRGAA
SCHEMBL23726494 0.73 ENPP2 (0.40) KDM4EALDH1A1CASP3GAAPKM
SCHEMBL12042103 0.72 ALDH1A1 (0.47) KDM4EALDH1A1GAAPKMPOLB
SCHEMBL23725934 0.72 HDAC1 (0.34) KDM4EALDH1A1POLB
SCHEMBL974116 0.70 KDM4E (0.40) KDM4EALDH1A1CASP3AHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
CN-115413275-A Substituted 1,1 , -biphenyl compounds and methods of use thereof 爱彼特生物制药公司 2022-11-29 CN disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL KDM4E 224/4885ALDH1A1 172/4885CASP3 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.